EcoR1 Capital LLC 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 5:47 pm Sale |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
EcoR1 Capital LLC | 0 0.000% |
-1,975,611 (Position Closed) |
Filing |
| 2022-04-11 4:26 pm Purchase |
2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
EcoR1 Capital LLC | 1,975,611 6.300% |
1,975,611 (New Position) |
Filing |